logo

VKTX Stock on the Rise: A Promising Investment

Viking Therapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $99.41 on 02/28/24, and the lowest price during the same period was recorded at $20.47 on 01/22/24.

52-week price history of VKTX Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Viking Therapeutics Inc’s current trading price is -66.93% away from its 52-week high, while its distance from the 52-week low is 60.58%. The stock’s price range during this period has fluctuated between $20.47 and $99.41. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 7.65 million for the day, which was evidently higher than the average daily volume of 4.59 million over the last three months.

Financial Performance and Market Capitalization

Viking Therapeutics Inc (VKTX) has experienced a quarterly decline of -49.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.66B and boasts a workforce of 27 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 55.89, with a change in price of -32.65. Similarly, Viking Therapeutics Inc recorded 3,954,874 in trading volume during the last 100 days, posting a change of -49.83%.

VKTX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

VKTX Stock Stochastic Average

Viking Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 5.80%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 16.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.08% and 3.58%, respectively.

VKTX Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -18.32% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -35.42%. Over the past 30 days, the price of VKTX has leaped by -29.61%. And in the last five days, it has fallen by -15.46%.

Most Popular